Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma

Glioblastoma is an immunologically ‘cold’ tumor, which are characterized by absent or minimal numbers of tumor-infiltrating lymphocytes (TILs). For those tumors that have been invaded by lymphocytes, they are profoundly exhausted and ineffective. While many immunotherapy approaches seek to reinvigor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kirit Singh, Kelly M. Hotchkiss, Kisha K. Patel, Daniel S. Wilkinson, Aditya A. Mohan, Sarah L. Cook, John H. Sampson
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/8aef5234162f41c9be3e1d253db29419
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8aef5234162f41c9be3e1d253db29419
record_format dspace
spelling oai:doaj.org-article:8aef5234162f41c9be3e1d253db294192021-11-11T15:29:19ZEnhancing T Cell Chemotaxis and Infiltration in Glioblastoma10.3390/cancers132153672072-6694https://doaj.org/article/8aef5234162f41c9be3e1d253db294192021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5367https://doaj.org/toc/2072-6694Glioblastoma is an immunologically ‘cold’ tumor, which are characterized by absent or minimal numbers of tumor-infiltrating lymphocytes (TILs). For those tumors that have been invaded by lymphocytes, they are profoundly exhausted and ineffective. While many immunotherapy approaches seek to reinvigorate immune cells at the tumor, this requires TILs to be present. Therefore, to unleash the full potential of immunotherapy in glioblastoma, the trafficking of lymphocytes to the tumor is highly desirable. However, the process of T cell recruitment into the central nervous system (CNS) is tightly regulated. Naïve T cells may undergo an initial licensing process to enter the migratory phenotype necessary to enter the CNS. T cells then must express appropriate integrins and selectin ligands to interact with transmembrane proteins at the blood–brain barrier (BBB). Finally, they must interact with antigen-presenting cells and undergo further licensing to enter the parenchyma. These T cells must then navigate the tumor microenvironment, which is rich in immunosuppressive factors. Altered tumoral metabolism also interferes with T cell motility. In this review, we will describe these processes and their mediators, along with potential therapeutic approaches to enhance trafficking. We also discuss safety considerations for such approaches as well as potential counteragents.Kirit SinghKelly M. HotchkissKisha K. PatelDaniel S. WilkinsonAditya A. MohanSarah L. CookJohn H. SampsonMDPI AGarticleimmunotherapyglioblastomablood–brain barriercentral nervous systemT cellsT lymphocytesNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5367, p 5367 (2021)
institution DOAJ
collection DOAJ
language EN
topic immunotherapy
glioblastoma
blood–brain barrier
central nervous system
T cells
T lymphocytes
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle immunotherapy
glioblastoma
blood–brain barrier
central nervous system
T cells
T lymphocytes
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Kirit Singh
Kelly M. Hotchkiss
Kisha K. Patel
Daniel S. Wilkinson
Aditya A. Mohan
Sarah L. Cook
John H. Sampson
Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
description Glioblastoma is an immunologically ‘cold’ tumor, which are characterized by absent or minimal numbers of tumor-infiltrating lymphocytes (TILs). For those tumors that have been invaded by lymphocytes, they are profoundly exhausted and ineffective. While many immunotherapy approaches seek to reinvigorate immune cells at the tumor, this requires TILs to be present. Therefore, to unleash the full potential of immunotherapy in glioblastoma, the trafficking of lymphocytes to the tumor is highly desirable. However, the process of T cell recruitment into the central nervous system (CNS) is tightly regulated. Naïve T cells may undergo an initial licensing process to enter the migratory phenotype necessary to enter the CNS. T cells then must express appropriate integrins and selectin ligands to interact with transmembrane proteins at the blood–brain barrier (BBB). Finally, they must interact with antigen-presenting cells and undergo further licensing to enter the parenchyma. These T cells must then navigate the tumor microenvironment, which is rich in immunosuppressive factors. Altered tumoral metabolism also interferes with T cell motility. In this review, we will describe these processes and their mediators, along with potential therapeutic approaches to enhance trafficking. We also discuss safety considerations for such approaches as well as potential counteragents.
format article
author Kirit Singh
Kelly M. Hotchkiss
Kisha K. Patel
Daniel S. Wilkinson
Aditya A. Mohan
Sarah L. Cook
John H. Sampson
author_facet Kirit Singh
Kelly M. Hotchkiss
Kisha K. Patel
Daniel S. Wilkinson
Aditya A. Mohan
Sarah L. Cook
John H. Sampson
author_sort Kirit Singh
title Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
title_short Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
title_full Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
title_fullStr Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
title_full_unstemmed Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma
title_sort enhancing t cell chemotaxis and infiltration in glioblastoma
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/8aef5234162f41c9be3e1d253db29419
work_keys_str_mv AT kiritsingh enhancingtcellchemotaxisandinfiltrationinglioblastoma
AT kellymhotchkiss enhancingtcellchemotaxisandinfiltrationinglioblastoma
AT kishakpatel enhancingtcellchemotaxisandinfiltrationinglioblastoma
AT danielswilkinson enhancingtcellchemotaxisandinfiltrationinglioblastoma
AT adityaamohan enhancingtcellchemotaxisandinfiltrationinglioblastoma
AT sarahlcook enhancingtcellchemotaxisandinfiltrationinglioblastoma
AT johnhsampson enhancingtcellchemotaxisandinfiltrationinglioblastoma
_version_ 1718435251690143744